ANKRD29, as a new prognostic and immunological biomarker of non–small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway

BACKGROUND: The predominant cancer-related deaths worldwide are caused by lung cancer, particularly non-small cell lung cancer (NSCLC), despite the fact that numerous therapeutic initiatives have been devised to improve the outcomes. Ankyrin repeat domain (ANKRD) is one of the widespread protein str...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hanqing, Wang, Yanbo, He, Yaomei, Zhang, Peng, Zeng, Cheng, Du, Tongxuan, Shen, Qiushuo, Zhao, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243072/
https://www.ncbi.nlm.nih.gov/pubmed/37277814
http://dx.doi.org/10.1186/s13062-023-00385-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243072/
https://www.ncbi.nlm.nih.gov/pubmed/37277814
http://dx.doi.org/10.1186/s13062-023-00385-7

Ejemplares similares